Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study - Ticau, S; Aldinc, E; Polydefkis, M; Patisiran Global OLE Collaborators (Amyloid, 2024)